for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Aethlon Medical, Inc.

AEMD.OQ

Latest Trade

2.65USD

Change

-0.02(-0.56%)

Volume

26,160

Today's Range

2.58

 - 

2.66

52 Week Range

1.19

 - 

4.34

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
2.66
Open
2.66
Volume
26,160
3M AVG Volume
40.34
Today's High
2.66
Today's Low
2.58
52 Week High
4.34
52 Week Low
1.19
Shares Out (MIL)
12.09
Market Cap (MIL)
31.91
Forward P/E
-4.75
Dividend (Yield %)
--

Next Event

Q3 2021 Aethlon Medical Inc Earnings Release

Latest Developments

More

Aethlon Medical Posts Qtrly Loss Per Share $0.15

Aethlon Medical Announces First Quarter Financial Results And Provides Corporate Update

Aethlon Medical Says At March 31, Had Cash Balance Of About $9.6 Mln

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Aethlon Medical, Inc.

Aethlon Medical, Inc. is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The Company's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are released to promote cancer progression and to seed the spread of metastasis. Through its subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based product candidates to diagnose and monitor neurological disorders and cancer.

Industry

Medical Equipment & Supplies

Contact Info

9635 Granite Ridge Dr Ste 100

SAN DIEGO, CA

92123

United States

+1.858.4597800

https://www.aethlonmedical.com/

Executive Leadership

Edward G. Broenniman

Chairman of the Board

Charles J. Fisher

Chief Executive Officer

James B. Frakes

Chief Financial Officer, Senior Vice President - Finance, Secretary

Guy F. Cipriani

Senior Vice President, Chief Business Officer

Steven Larosa

Chief Medical Officer

Key Stats

2.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

0.0K

2019

0.0K

2020

0.0K

2021(E)

0.0K
EPS (USD)

2018

-6.900

2019

-5.100

2020

-1.870

2021(E)

-0.610
Price To Earnings (TTM)
--
Price To Sales (TTM)
51.46
Price To Book (MRQ)
2.33
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
-83.04
Return on Equity (TTM)
-70.86

Latest News

Latest News

BRIEF-Aethlon Medical Says At March 31, Had Cash Balance Of About $9.6 Mln

* AETHLON MEDICAL ANNOUNCES FISCAL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

BRIEF-Aethlon Announces FDA Approval Of IDE Supplement For COVID-19 Patients

* AETHLON ANNOUNCES FDA APPROVAL OF IDE SUPPLEMENT FOR COVID-19 PATIENTS

BRIEF-Aethlon Medical Files Prospectus Relates To Common Stock Offer

* AETHLON MEDICAL FILES PROSPECTUS RELATES TO OFFER, ISSUANCE, SALE FROM TIME TO TIME OF COMMON STOCK HAVING AGGREGATE OFFERING PRICE OF UP TO $7.5 MILLION Source text: https://bit.ly/2Jt5wZ4 Further company coverage:

BRIEF-Aethlon Medical Says SEC Order For Halt In Trading Of Co's Stock Expires

* AETHLON MEDICAL - SEC ORDER FOR HALT IN TRADING OF AETHLON MEDICAL STOCK EXPIRES Source text for Eikon: Further company coverage:

BRIEF-Aethlon Medical Says Appointed Timothy Rodell As CEO

* AETHLON MEDICAL INC - EFFECTIVE AS OF FEB 14 APPOINTED TIMOTHY C. RODELL, AS CEO OF CO

BRIEF-Aethlon Medical Reports Q3 Diluted Net Loss Of $0.28

* AETHLON MEDICAL ANNOUNCES THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

BRIEF-SEC Order For Halt In Trading Of Aethlon Medical Stock

* SECURITIES AND EXCHANGE COMMISSION (SEC) ORDER FOR HALT IN TRADING OF AETHLON MEDICAL (NASDAQ:AEMD) STOCK

BRIEF-Aethlon Medical Participates In Informational Meeting With FDA​

* AETHLON MEDICAL SAYS ON MARCH 20, CO PARTICIPATED IN AN INFORMATIONAL MEETING WITH FDA - SEC FILING

BRIEF-Aethlon Medical Announces Fiscal 2018 Third Quarter Results

* AETHLON MEDICAL ANNOUNCES FISCAL 2018 THIRD QUARTER RESULTS

BRIEF-Aethlon Medical Says Granted U.S. Patent That Broadens Protection For The Aethlon Hemopurifier

* AETHLON MEDICAL ANNOUNCES ALLOWANCE OF U.S. PATENT THAT BROADENS PROTECTION FOR THE AETHLON HEMOPURIFIER® TO TREAT VIRAL INFECTIONS Source text for Eikon: Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up